E. Audureau, A. Chivet, R. Ursu, R. Corns, P. Metellus, G. Noel, S. Zouaoui, J. Guyotat, P. Le Reste, T. Faillot, F. Litré, N. Desse, A. Petit, É. Emery, E. Lechapt-Zalcman, J. Peltier, J. Duntze, E. Dezamis, J. Voirin, P. Menei, F. Caire, P. Dam Hieu, J. Barat, O. Langlois, J. Vignes, P. Fabbro‐Peray, Adeline Riondel, Elodie Sorbets, M. Zanello, A. Roux, A. Carpentier, L. Bauchet, J. Pallud
2018.2.1JOURNAL OF NEURO-ONCOLOGY
tlooto Summary
Age, KPS at progression, RTOG–RPA classes, surgical resection at progression and chemotherapy at progression are prognostic for survival in recurrent glioblastomas and should inform the treatment decisions.
Abstract
Abstract is not available.
Citation format
AUDUREAU, E., et al. Prognostic factors for survival in adult patients with recurrent glioblastoma: A decision-tree-based model. JOURNAL OF NEURO-ONCOLOGY, 2018, 136: 565–576.